Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sundance Diagnostics logo — company profile

Sundance Diagnostics

Founded 2012 1 employees Seed Total: $6.51K Biotechnology, Health Care

General Information

Company Name Sundance Diagnostics
Founded Year 2012
Employees 1
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Sundance Diagnostics. To contact Sundance Diagnostics, visit sundancedx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sundance Diagnostics compare?

A PDF of Sundance Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sundance Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sundance Diagnostics

Sundance Diagnostics is a biotechnology startup that was founded in 2012 and operates out of Grand Junction, Colorado. The company is pioneering the development of genetic tests aimed at predicting a patient’s risk of experiencing suicidal thoughts or behavior as a side effect of antidepressants. This innovation responds to a critical demand in the healthcare industry to enhance the safety of pharmaceutical drugs, particularly those with severe side effects used by millions of people. Sundance Diagnostics utilizes the most advanced genetic technologies to create safety tests that can forecast a patient’s risk, with the primary objectives of saving lives, improving treatment outcomes, bolstering patient confidence, and reducing healthcare costs. The company received a $5.51K Seed Round investment on May 19, 2015.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $5.51K -
19 May 2015
Seed Round $1.00K -
04 Mar 2013

FAQ About Sundance Diagnostics

Sundance Diagnostics is pioneering the development of genetic tests designed to predict a patient’s risk of experiencing suicidal thoughts or behavior as a side effect of antidepressants. There is a critical demand to enhance the safety of pharmaceutical drugs, especially those with severe side effe...
Sundance Diagnostics was founded in 2012.
Sundance Diagnostics operates in Biotechnology and Health Care.
Sundance Diagnostics has approximately 1 employees.
Sundance Diagnostics has completed 2 funding rounds, raising a total of $6.51K. The latest funding stage is Seed.

We're actively collecting intelligence on Sundance Diagnostics.

Source: BounceWatch company record for Sundance Diagnostics, https://bouncewatch.com/company/sundance-diagnostics, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes